Lanean...
Current perspectives for the treatment of chronic myeloid leukemia
With an annual incidence of 1–2 in a million, Ph*(+) chronic myeloid leukemia (CML) is a clonal hematopoietic stem cell disease that makes myeloid neoplastic cells breed out of control. This BCR-ABL(+) myeloproliferative disease makes up about 15%–20% of all leukemia cases in adults. CML is seen mor...
Gorde:
| Argitaratua izan da: | Turk J Med Sci |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The Scientific and Technological Research Council of Turkey
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7350850/ https://ncbi.nlm.nih.gov/pubmed/30761815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-1810-81 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|